Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Convertible Notes, Added, 2024 Q3

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Convertible Notes, Added

In convertible notes that pay a coupon (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,005 positions, added to 266, reduced 334 and sold out of 965.

  • Q3 2024: Stock HALOZYME THERAPEUTICS INC; Country of operation United States; Class NOTE 1.000% 8/1; Principal before $13,200,000.
  • Q3 2024: Stock SEA LTD; Country of operation —; Class NOTE 2.375%12/0; Principal before $6,000,000.
  • Q3 2024: Stock IMPINJ INC; Country of operation —; Class NOTE 1.125% 5/1; Principal before $45,000,000.
  • Q3 2024: Stock DATADOG INC; Country of operation —; Class NOTE 0.125% 6/1; Principal before $40,000,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q3 2024HALOZYME THERAPEUTICS INC
CUSIP 40637HAF6		United StatesNOTE 1.000% 8/1$13,200,000$58,371,000+45,171,000$14,696,331$69,524,602+$54,828,2712024-11-14
Q3 2024SEA LTD
CUSIP 81141RAF7		—NOTE 2.375%12/0$6,000,000$25,000,000+19,000,000$6,429,854$30,019,761+$23,589,9072024-11-14
Q3 2024IMPINJ INC
CUSIP 453204AD1		—NOTE 1.125% 5/1$45,000,000$46,100,000+1,100,000$69,838,907$92,353,747+$22,514,8402024-11-14
Q3 2024DATADOG INC
CUSIP 23804LAB9		—NOTE 0.125% 6/1$40,000,000$60,000,000+20,000,000$57,903,860$77,976,958+$20,073,0982024-11-14
Q3 2024STRIDE INC
CUSIP 86333MAA6		United StatesNOTE 1.125% 9/0$23,500,000$29,500,000+6,000,000$33,706,337$49,664,950+$15,958,6132024-11-14
Q3 2024MONGODB INC
CUSIP 60937PAD8		—NOTE 0.250% 1/1$75,000,000$81,000,000+6,000,000$98,768,035$111,768,672+$13,000,6372024-11-14
Q3 2024PEABODY ENGR CORP
CUSIP 704551AD2		—NOTE 3.250% 3/0$25,000,000$30,000,000+5,000,000$32,949,518$45,003,099+$12,053,5812024-11-14
Q3 2024LANTHEUS HLDGS INC
CUSIP 516544AB9		—NOTE 2.625%12/1$6,500,000$12,510,000+6,010,000$8,113,903$19,456,945+$11,343,0422024-11-14
Q3 2024VENTAS RLTY LTD PARTNERSHIP
CUSIP 92277GAZ0		—NOTE 3.750% 6/0$550,000$9,500,000+8,950,000$577,911$11,564,067+$10,986,1562024-11-14
Q3 2024LUMENTUM HLDGS INC
CUSIP 55024UAD1		—NOTE 0.500%12/1$1,500,000$10,000,000+8,500,000$1,354,405$9,838,154+$8,483,7492024-11-14
Q3 2024PATRICK INDS INC
CUSIP 703343AG8		United StatesNOTE 1.750%12/0$14,600,000$16,368,000+1,768,000$17,709,270$24,852,099+$7,142,8292024-11-14
Q3 2024BURLINGTON STORES INC
CUSIP 122017AB2		—NOTE 2.250% 4/1$13,000,000$17,878,000+4,878,000$15,286,890$22,313,214+$7,026,3242024-11-14
Q3 2024ALTAIR ENGR INC
CUSIP 021369AC7		—NOTE 1.750% 6/1$10,000,000$15,000,000+5,000,000$14,553,375$21,424,256+$6,870,8812024-11-14
Q3 2024NUTANIX INC
CUSIP 67059NAH1		United StatesNOTE 0.250%10/0$25,000,000$30,000,000+5,000,000$29,162,661$35,888,953+$6,726,2922024-11-14
Q3 2024MICROCHIP TECHNOLOGY INC.
CUSIP 595017AU8		—NOTE 0.125%11/1$14,000,000$20,000,000+6,000,000$14,772,492$19,930,061+$5,157,5692024-11-14
Q3 2024CONMED CORP
CUSIP 207410AH4		—NOTE 2.250% 6/1$29,402,000$33,665,000+4,263,000$26,352,613$31,303,326+$4,950,7132024-11-14
Q3 2024RIVIAN AUTOMOTIVE INC
CUSIP 76954AAB9		—NOTE 4.625% 3/1$12,500,000$18,000,000+5,500,000$12,261,668$16,252,534+$3,990,8662024-11-14
Q3 2024NORTHERN OIL & GAS INC
CUSIP 665531AJ8		—NOTE 3.625% 4/1$45,965,000$47,500,000+1,535,000$53,168,957$54,402,266+$1,233,3092024-11-14